Selected research
Industry Growth & Trends
Global OAB Treatment Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global OAB Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the OAB Treatment market include Astellas Pharma, Kyorin Pharmaceutical, AbbVie, Pfizer, Johnson & Johnson and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global OAB Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The OAB Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OAB Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OAB Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global OAB Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
OAB Treatment Market by Company
Astellas Pharma
Kyorin Pharmaceutical
AbbVie
Pfizer
Johnson & Johnson
Teva
OAB Treatment Segment by Type
Botox
Mirabegron
Anticholinergics
Others
OAB Treatment Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
OAB Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OAB Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OAB Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OAB Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of OAB Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Botox
- Mirabegron
- Anticholinergics
- Others
Applications
- Idiopathic Overactive Bladder
- Neurogenic Overactive Bladder
Companies covered
- Astellas Pharma
- Kyorin Pharmaceutical
- AbbVie
- Pfizer
- Johnson & Johnson
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global OAB Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global OAB Treatment Market Size by Region (2021-2032)
- 1.4.1 Global OAB Treatment Market Size by Region (2021-2026)
- 1.4.2 Global OAB Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions OAB Treatment Market Size (2021-2032)
- 1.5.1 North America OAB Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe OAB Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific OAB Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America OAB Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa OAB Treatment Market Size Growth Rate (2021-2032)
2 OAB Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Botox
- 2.1.2 Mirabegron
- 2.1.3 Anticholinergics
- 2.1.4 Others
- 2.2 Global OAB Treatment Market Size by Type
- 2.2.1 Global OAB Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global OAB Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global OAB Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global OAB Treatment Market Size by Regions
- 2.3.1 North America OAB Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe OAB Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific OAB Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America OAB Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa OAB Treatment Market Size Breakdown by Type (2021-2026)
3 OAB Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Idiopathic Overactive Bladder
- 3.1.2 Neurogenic Overactive Bladder
- 3.2 Global OAB Treatment Market Size by Application
- 3.2.1 Global OAB Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global OAB Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global OAB Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global OAB Treatment Market Size by Regions
- 3.3.1 North America OAB Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe OAB Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific OAB Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America OAB Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa OAB Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 OAB Treatment Industry Trends
- 4.2 OAB Treatment Industry Drivers
- 4.3 OAB Treatment Industry Opportunities and Challenges
- 4.4 OAB Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by OAB Treatment Revenue (2021-2026)
- 5.2 Global OAB Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global OAB Treatment Key Company Headquarters & Area Served
- 5.4 Global OAB Treatment Company, Product Type & Application
- 5.5 Global OAB Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global OAB Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 OAB Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 OAB Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Astellas Pharma
- 6.1.1 Astellas Pharma Company Information
- 6.1.2 Astellas Pharma Business Overview
- 6.1.3 Astellas Pharma OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Astellas Pharma OAB Treatment Product Portfolio
- 6.1.5 Astellas Pharma Recent Developments
- 6.2 Kyorin Pharmaceutical
- 6.2.1 Kyorin Pharmaceutical Company Information
- 6.2.2 Kyorin Pharmaceutical Business Overview
- 6.2.3 Kyorin Pharmaceutical OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Kyorin Pharmaceutical OAB Treatment Product Portfolio
- 6.2.5 Kyorin Pharmaceutical Recent Developments
- 6.3 AbbVie
- 6.3.1 AbbVie Company Information
- 6.3.2 AbbVie Business Overview
- 6.3.3 AbbVie OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 AbbVie OAB Treatment Product Portfolio
- 6.3.5 AbbVie Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Pfizer OAB Treatment Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Johnson & Johnson OAB Treatment Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Teva
- 6.6.1 Teva Company Information
- 6.6.2 Teva Business Overview
- 6.6.3 Teva OAB Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Teva OAB Treatment Product Portfolio
- 6.6.5 Teva Recent Developments
7 North America
- 7.1 North America OAB Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America OAB Treatment Market Size by Country (2021-2026)
- 7.3 North America OAB Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe OAB Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe OAB Treatment Market Size by Country (2021-2026)
- 8.3 Europe OAB Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific OAB Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific OAB Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific OAB Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America OAB Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America OAB Treatment Market Size by Country (2021-2026)
- 10.3 South America OAB Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa OAB Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa OAB Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa OAB Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst